✦ LIBER ✦

Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

✍ Scribed by Kim, S. T.; Lim, D. H.; Jang, K.-T.; Lim, T.; Lee, J.; Choi, Y.-L.; Jang, H.-L.; Yi, J. H.; Baek, K. K.; Park, S. H.; Park, Y. S.; Lim, H. Y.; Kang, W. K.; Park, J. O.

Book ID: 127089837
Publisher: American Association for Cancer Research
Year: 2011
Tongue: English
Weight: 322 KB
Volume: 10
Category: Article
ISSN: 1535-7163
DOI: 10.1158/1535-7163.mct-11-0269

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid deaminator status is associated wi

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

✍ Serdjebi, Cindy; Seitz, Jean-François; Ciccolini, Joseph; Duluc, Muriel; Norguet 📂 Article 📅 2013 🏛 Future Medicine 🌐 English ⚖ 756 KB

Association of RRM1 –37A>C polymorphism

Association of RRM1 –37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

✍ J. Rodriguez; V. Boni; A. Hernández; N. Bitarte; R. Zarate; M. Ponz-Sarvisé; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 353 KB

FOLFIRINOX as second-line chemotherapy i

FOLFIRINOX as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy

✍ Lee, M.G.; Lee, Sang Hyub; Hwang, J.H.; Ryu, J.K.; Kim, Y.T.; Kim, D.U.; Woo, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

6108 Association of FcGammaRIIa-FcGammaR

6108 Association of FcGammaRIIa-FcGammaRIIIa polymorphisms and KRAS mutations with clinical outcome in advanced colorectal cancer patients treated with antiEGFR based treatment

✍ Paez, D.; Espinosa, I.; Altés, A.; del Rio, E.; Salazar, J.; Barnadas, A.; Marcu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Matrix metalloproteinase-2 polymorphisms

Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy

✍ Xueying Zhao; Xun Wang; Wenting Wu; Zhiqiang Gao; Junjie Wu; David H. Garfield; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Clinical outcome of patients with doceta

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy

✍ Thomas Nelius; Tobias Klatte; Werner de Riese; Allan Haynes; Stephanie Filleur 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 201 KB